Helsinki, Finland, 22 December 2023: Charles MacBain, the CEO and a primary
insider of Nordhealth AS (the "Company"), has today sold 1,650,316 class A
shares in the Company at a price of NOK 21.34 per share, in two separate
transactions to family members who have agreed to vote and dispose of the shares
with Charles MacBain.

Following the transactions, Charles MacBain owns 5,773,507 class A shares in the
Company. In addition, he holds 24,289,319 class B shares, in total 30,062,826
shares.

Please refer to the attached notifications in accordance with the Market Abuse
Regulation article 19 for further details.

For further information, please contact:
Charles MacBain, CEO
charles.macbain@nordhealth.com
+44 75 3903 2200

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 50,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries. Headquartered in Helsinki, Finland, Nordhealth has a solid footprint
in the Nordic region and a growing presence internationally, with more than 380
employees working either remotely or from offices (collaboration hubs). Visit
the company's website at nordhealth.comÂ (http://www.nordhealth.com.